Showing results (341-350 of 2,469) with videos related to
Sort By:
Pageof 247
The Journal of Headache and Pain|March 31, 2009
Cerebral infarct presenting with thunderclap headacheBengt A Edvardsson, Staffan PerssonThe Journal of Headache and Pain|March 31, 2009
Calcitonin gene-related peptide in blood: is it increased in the external jugular vein during migraine and cluster headache? A reviewPeer Tfelt-Hansen, Han LeThe Journal of Headache and Pain|September 15, 2022
Preventive treatment can reverse cognitive impairment in chronic migraineCristina González-Mingot, Anna Gil-Sánchez, Marc Canudes-Solans, et al.The Journal of Headache and Pain|September 29, 2022
Exploring the neurobiology of the premonitory phase of migraine preclinically - a role for hypothalamic kappa opioid receptors?Caroline M Kopruszinski, Robson Vizin, Moe Watanabe, et al.The Journal of Headache and Pain|September 16, 2022
A systematic review of economic evaluations of pharmacological treatments for adults with chronic migraineSaval Khanal, Martin Underwood, Seyran Naghdi, et al.The Journal of Headache and Pain|October 4, 2022
Cerebral blood flow alterations in migraine patients with and without aura: An arterial spin labeling studyTong Fu, Lindong Liu, Xiaobin Huang, et al.The Journal of Headache and Pain|August 29, 2022
Impact of fremanezumab on disability outcomes in patients with episodic and chronic migraine: a pooled analysis of phase 3 studiesPeter McAllister, Joshua M Cohen, Verena Ramirez Campos, et al.The Journal of Headache and Pain|October 21, 2022
Cardiac cephalalgia: a narrative review and ICHD-3 criteria evaluationMaría Pilar Navarro-Pérez, Elena Bellosta-Diago, Jes Olesen, et al.The Journal of Headache and Pain|December 5, 2023
What to do with non-responders to CGRP(r) monoclonal antibodies: switch to another or move to gepants?Marta Waliszewska-Prosół, Doga Vuralli, Paolo MartellettiThe Journal of Headache and Pain|November 22, 2023
Long-term effectiveness and tolerability of galcanezumab in patients with migraine excluded from clinical trials: real world evidence of 1055 patients with 1 year follow-up from the Galca-Only registryVictor Obach, Fernando Velasco, Rocio Alvarez Escudero, et al.Pageof 247